This inventor holds 1 USPTO granted patent. Top assignee: Oklahoma Medical Research Foundation. Active years: 2007.
Company Filing History:
Years Active: 2007
Title: J Keith McClung: Innovator in Cancer Research
Introduction
J Keith McClung is a notable inventor based in Radford, VA (US). He has made significant contributions to the field of cancer research through his innovative work. His research focuses on the 3' untranslated region of the human prohibitin gene, which has implications for cancer susceptibility screening and therapeutic applications.
Latest Patents
J Keith McClung holds 1 patent related to his research. His patent involves the isolation of the 3' untranslated region of the human prohibitin gene, which is being explored for its potential use in cancer susceptibility screening and as a therapeutic agent for cancer treatment.
Career Highlights
McClung is affiliated with the Oklahoma Medical Research Foundation, where he continues to advance his research in cancer biology. His work has garnered attention for its potential impact on understanding cancer susceptibility and developing new treatment strategies.
Collaborations
He has collaborated with esteemed colleagues, including Robert T Dell'Orco and Xiao-Tie Liu, to further his research endeavors. These collaborations have enriched his work and contributed to the advancement of cancer research.
Conclusion
J Keith McClung's innovative contributions to cancer research highlight the importance of genetic studies in understanding and treating cancer. His work continues to inspire advancements in the field.